Gladstone Institutional Advisory LLC Personalis, Inc. Transaction History

Gladstone Institutional Advisory LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$12.24 - $21.25 $140,760 - $244,375	-11,500 Closed	0 $0
Q2 2021 Jan 27, 2023	SELL	$18.15 - $27.75 $9,075 - $13,875	-500 Reduced 4.17%	11,500 $291,000
Q2 2021 Aug 13, 2021	SELL	$18.15 - $27.75 $9,075 - $13,875	-500 Reduced 4.17%	11,500 $291,000
Q1 2021 Jan 27, 2023	SELL	$20.71 - $51.02 $32,100 - $79,081	-1,550 Reduced 11.44%	12,000 $295,000
Q1 2021 May 17, 2021	SELL	$20.71 - $51.02 $32,100 - $79,081	-1,550 Reduced 11.44%	12,000 $295,000
Q4 2020 Jan 27, 2023	BUY	$21.84 - $44.0 $295,932 - $596,200	13,550 New	13,550 $496,000
Q4 2020 Feb 16, 2021	BUY	$21.84 - $44.0 $295,932 - $596,200	13,550 New	13,550 $496,000

30M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $225M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.